Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409900 · ClinicalTrials.gov registry record · NA
Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty
A NA study of Osteoarthritis and Total Hip Arthroplasty, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03409900 is a NA study of Osteoarthritis and Total Hip Arthroplasty that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 44 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03409900, a NA study of Osteoarthritis and Total Hip Arthroplasty, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis. In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed to the more traditional posterolateral approach (PLA). The literature supports that DAA is superior to PLA with regard to lower blood loss, less pain, shorter hospital stay, and faster rehabilitation. Traditionally the study team has performed Lumbar Plexus blocks (LPB) to provide post-operative analgesia for total hip arthroplasty. The quadratus lumborum block (QLB) is a newer regional analgesic technique that may be as effective as LPB at providing pain control following DAA hip arthroplasty. This study is designed to compare the efficacy, with regards to post-operative pain management, between LPB and QLB following a DAA total hip arthroplasty.
Conditions Studied
Interventions
- OTHER LPB
- OTHER QLB
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2019-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409900
The ClinicalTrials.gov registry entry for NCT03409900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which LPB is the first listed.
NCT03409900 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03409900 about?
NCT03409900 is a clinical study titled "Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty". Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis. In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed...
What is the current status of trial NCT03409900?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-03-04. Estimated completion is 2019-11-22.
What conditions does trial NCT03409900 study?
This clinical trial studies the following conditions: Osteoarthritis, Total Hip Arthroplasty.
What interventions are being tested in trial NCT03409900?
The interventions under investigation include: LPB (OTHER), QLB (OTHER).
Who is sponsoring clinical trial NCT03409900?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409900 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.